Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia.

× No keyword cloud information.

11 in total

1. Severe autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia responsive to fludarabine-based treatment.

Authors: S Tosti; R Caruso; F D'Adamo; A Picardi; M Ali Ege; G Girelli; F R Mauro; L Maurillo; S Amadori
Journal: Ann Hematol Date: 1992-11 Impact factor: 3.673

Review 2. Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review.

Authors: Peter Valent; Klaus Lechner
Journal: Wien Klin Wochenschr Date: 2008 Impact factor: 1.704

3. Alemtuzumab therapy for severe autoimmune hemolysis in a patient with B-cell chronic lymphocytic leukemia.

Authors: Jeanette Lundin; Claes Karlsson; Fredrik Celsing
Journal: Med Oncol Date: 2006 Impact factor: 3.064

Review 4. Fludarabine. An update of its pharmacology and use in the treatment of haematological malignancies.

Authors: J C Adkins; D H Peters; A Markham
Journal: Drugs Date: 1997-06 Impact factor: 9.546

Review 5. Management of chronic lymphocytic leukaemia.

Authors: N Kalil; B D Cheson
Journal: Drugs Aging Date: 2000-01 Impact factor: 3.923

Review 6. Achieving optimal outcomes in chronic lymphocytic leukaemia.

Authors: T J Hamblin
Journal: Drugs Date: 2001 Impact factor: 9.546

Review 7. Chronic lymphocytic leukemia and autoimmunity: a systematic review.

Authors: Kate Hodgson; Gerardo Ferrer; Emili Montserrat; Carol Moreno
Journal: Haematologica Date: 2011-01-17 Impact factor: 9.941

Review 8. Fludarabine. A review of its pharmacological properties and therapeutic potential in malignancy.

Authors: S R Ross; D McTavish; D Faulds
Journal: Drugs Date: 1993-05 Impact factor: 9.546

Review 9. Immunological and genetic abnormalities in chronic lymphocytic leukaemia. Impact of the purine analogues.

Authors: G Juliusson
Journal: Drugs Date: 1994 Impact factor: 9.546

10. The use of monoclonal antibodies in the treatment of autoimmune complications of chronic lymphocytic leukemia.

Authors: Luca Laurenti; Barbara Vannata; Idanna Innocenti; Francesco Autore; Francesco Santini; Simona Sica; Dimitar G Efremov
Journal: Mediterr J Hematol Infect Dis Date: 2013-04-10 Impact factor: 2.576